Opiant Pharmaceuticals Inc (NASDAQ:OPNT)

19.98
Delayed Data
As of Apr 23
 +0.14 / +0.71%
Today’s Change
5.00
Today|||52-Week Range
51.90
-13.02%
Year-to-Date
No recent news for Opiant Pharmaceuticals Inc.

Today’s Trading

Previous close19.84
Today’s open19.92
Day’s range19.62 - 19.98
Volume12,379
Average volume (3 months)53,412
Market cap$51.5M
Data as of 4:00pm ET, 04/23/2018

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+86.37%
P/E ratio42.5
Price/Sales1.58
Price/Book9.49

Competitors

 Today’s
change
Today’s
% change
APDNApplied DNA Sciences...-0.01-0.69%
XENEXenon Pharmaceutical...+0.08+1.49%
PLXPPLX Pharma Inc+0.10+2.41%
CASICASI Pharmaceuticals...+0.15+2.19%
Data as of 4:00pm ET, 04/23/2018

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$18.4M
Annual profit (last year)$6.6M
Net profit margin35.68%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, Director &
Head-Media Relations
Roger Crystal
Chief Financial Officer
David D. O'Toole
Corporate headquarters
Santa Monica, California

Forecasts